Detalhe da pesquisa
1.
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study.
Biol Blood Marrow Transplant
; 26(9): 1679-1688, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32592857
2.
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 26(12): 2306-2310, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961372
3.
Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(11): 2075-2081, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818556
4.
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant
; 26(3): 502-508, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31730920
5.
Isohemagglutinin titering performed on an automated solid-phase and hemagglutinin-based analyzer is comparable to results obtained by manual gel testing.
Transfusion
; 60(3): 628-636, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31957889
6.
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 25(6): 1128-1135, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30599208
7.
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2431-2437, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394272
8.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood
; 129(10): 1389-1393, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049637
9.
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab.
J Neurooncol
; 145(3): 467, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758486
10.
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab.
J Neurooncol
; 145(3): 461-466, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621040
11.
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.
Biol Blood Marrow Transplant
; 24(10): 2056-2064, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909152
12.
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1022-1028, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353109
13.
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors.
Biol Blood Marrow Transplant
; 24(5): 1099-1102, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29452245
14.
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(11): 1903-1909, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28711728
15.
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Blood
; 125(19): 3024-31, 2015 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814532
16.
Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton's tyrosine kinase inhibitor vecabrutinib in B-cell malignancies.
Haematologica
; 107(4): 984-987, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937320
17.
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
Haematologica
; 102(2): 391-400, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846611
18.
ECMO Therapy for Cardiac Lymphoma.
Circulation
; 142(12): 1219-1223, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32955940
19.
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.
Blood
; 124(25): 3817-27, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316679
20.
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.
Ann Intern Med
; 173(10): 852-853, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628535